Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

Local pharmacies say they’re struggling to afford GLP-1s

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Harry Webb has seen a flurry of

November 1, 2023

Shortages of generic drugs can’t be blamed solely on group purchasing organizations

The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was one of the most significant cost-reducing policy innovations of the

April 25, 2024

Merck’s next big thing is (probably) on the way

New biotech newsletter launching this Thursday. Don’t miss out. Hello, everyone. Damian here with a look at a pivotal FDA approval, good news for a small

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.